Home/Filings/4/0000899243-23-005897
4//SEC Filing

DAMME LAURA 4

Accession 0000899243-23-005897

CIK 0001756262other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 8:00 PM ET

Size

7.2 KB

Accession

0000899243-23-005897

Insider Transaction Report

Form 4
Period: 2023-02-20
DAMME LAURA
VP, Clinical Affairs
Transactions
  • Award

    Common Stock

    2023-02-20+5,6855,685 total
  • Award

    Stock Option (Right to Buy)

    2023-02-20+8,7058,705 total
    Exercise: $66.10Exp: 2033-02-20Common Stock (8,705 underlying)
Footnotes (2)
  • [F1]Includes 5,685 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service.

Issuer

TransMedics Group, Inc.

CIK 0001756262

Entity typeother

Related Parties

1
  • filerCIK 0001784433

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 8:00 PM ET
Size
7.2 KB